0001415889-23-012152.txt : 20230811
0001415889-23-012152.hdr.sgml : 20230811
20230811173020
ACCESSION NUMBER: 0001415889-23-012152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230809
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDERSON A SCOTT
CENTRAL INDEX KEY: 0001184825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-18592
FILM NUMBER: 231165330
MAIL ADDRESS:
STREET 1: ONE SOUTH MAIN, SUITE 1134
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC
CENTRAL INDEX KEY: 0000856982
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 870447695
STATE OF INCORPORATION: UT
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1600 WEST MERIT PARK WAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 8012531600
MAIL ADDRESS:
STREET 1: 1600 WEST MERIT PARKWAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
4
1
form4-08112023_090814.xml
X0508
4
2023-08-09
0000856982
MERIT MEDICAL SYSTEMS INC
MMSI
0001184825
ANDERSON A SCOTT
1600 WEST MERIT PARKWAY
SOUTH JORDAN
UT
84095
true
false
false
false
0
Common Stock, No Par Value
2023-08-09
4
M
0
25000
50.50
A
71397
D
Common Stock, No Par Value
2023-08-09
4
S
0
22180
69.40
D
49217
D
Non-qualified stock options (right to buy)
50.5
2023-08-09
4
M
0
25000
0
D
2019-06-07
2025-06-07
Common Stock
25000
0
D
Non-qualified stock options (right to buy)
52.17
2020-05-24
2026-05-24
Common Stock
13750
13750
D
Non-qualified stock options (right to buy)
52.17
2020-05-31
2026-05-31
Common Stock
7500
7500
D
The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.00 to $69.91 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.
/s/ Brian G. Lloyd, Attorney-in-Fact
2023-08-11